USE OF NADH AND NMN IN PREPARATION OF DRUGS OR HEALTH-CARE PRODUCTS FOR TREATING PARKINSON'S DISEASE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20170080011A1
SERIAL NO

15311797

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Disclosed is use of nicotinamide adenine dinucleotide (NADH) and β-nicotinamide mononucleotide (NMN) in the preparation of drugs or health-care products for treating Parkinson's disease, in which β-NADH and βs-NMN are produced enzymatically.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BONTAC BIO-ENGINEERING (SHENZHEN) CO LTD518000 BUILDING 3B-130 HENGTAI YU BUILDING TANGWEI COMMUNITY FENGHUANG STREET GUANGMING DISTRICT SHENZHEN CITY GUANGDONG PROVINCE SHENZHEN CITY GUANGDONG PROVINCE 518000

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
FU, Rongzhao Shenzhen, CN 24 42
ZHANG, Qi Shenzhen, CN 768 6016

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation